Free Trial
NASDAQ:UG

United-Guardian Q2 2025 Earnings Report

United-Guardian logo
$7.90 -0.04 (-0.50%)
Closing price 08/8/2025 03:57 PM Eastern
Extended Trading
$7.98 +0.08 (+1.01%)
As of 08/8/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

United-Guardian EPS Results

Actual EPS
$0.14
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

United-Guardian Revenue Results

Actual Revenue
$2.84 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

United-Guardian Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Friday, August 8, 2025
Conference Call Time
9:00AM ET

United-Guardian Earnings Headlines

United-Guardian Reports Second Quarter Results
United-Guardian, Inc. (UG) - Yahoo Finance
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
UG United-Guardian, Inc. - Seeking Alpha
United-Guardian Reports 2024 Financial Results
See More United-Guardian Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like United-Guardian? Sign up for Earnings360's daily newsletter to receive timely earnings updates on United-Guardian and other key companies, straight to your email.

About United-Guardian

United-Guardian (NASDAQ:UG) manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. The company was founded in 1942 and is based in Hauppauge, New York.

View United-Guardian Profile

More Earnings Resources from MarketBeat